Clinical Trial Update: Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating the regenerative capacity of CardioCell in patients with no-option critical limb ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• CardioCell

Snippet

Sponsor: John Paul II Hospital, Krakow | Conditions: Critical Limb Ischemia | Phase 2, Phase 3 | Status: UNKNOWN